Clinical and non-targeted metabolomic profiling of homozygous carriers of Transcription Factor 7-like 2 variant rs7903146

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Wagner, Robert ^a,b,c   Li, Jia ^d   Kenar, Erhan ^b   Kohlbacher, Oliver ^b   Machicao, Fausto ^a,b,c   Häring, Hans Ulrich ^a,b,c   Fritsche, Andreas ^a,b,c   Xu, Guowang ^d   Lehmann, Rainer ^a,b,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FATTY ACID; GLUCOSE BLOOD LEVEL; INSULIN; TCF7L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR 7 LIKE 2;

ADULT; BLOOD; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMOZYGOTE; HUMAN; MALE; METABOLISM; METABOLOME; METABOLOMICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PROCEDURES; RISK FACTOR; SECRETION (PROCESS); SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE TOLERANCE TEST; HOMOZYGOTE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84902440103     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05296     Document Type: Article

References (32)

1. Helgason, A. et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat. Genet. 39, 218-225 (2007 (Pubitemid 46184353)
2. Renstrom, E. Impact of transcription factor 7-like 2 (TCF7L2) on pancreatic islet function and morphology in mice and men. Diabetologia 55, 2559-2561 (2012
3. Lyssenko, V. et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J. Clin. Invest 117, 2155-2163 (2007 (Pubitemid 47219560)
4. Gjesing, A. P. et al. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test. Diabetologia 54, 103-110 (2011
5. Shu, L. et al. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 57, 645-653 (2008
6. McCarthy, M. I., Rorsman, P. & Gloyn, A. L. TCF7L2 and Diabetes: A Tale of Two Tissues, and of Two Species. Cell Metab 17, 157-159 (2013
7. Le Bacquer, O. et al. TCF7L2 rs7903146 impairs islet function andmorphology in non-diabetic individuals. Diabetologia 55, 2677-2681 (2012
8. da Silva Xavier, G. et al. Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice. Diabetologia 55, 2667-2676 (2012
9. Boj, S. F. et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151, 1595-1607 (2012
10. Ross, S. E. et al. Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953 (2000 (Pubitemid 30659947)
11. Shao, W. et al. The Wnt signaling pathway effector TCF7L2 controls gut and brain proglucagon gene expression and glucose homeostasis. Diabetes 62, 789-800 (2013
12. Grant, S. F. Understanding the elusive mechanism of action of TCF7L2 in metabolism. Diabetes 61, 2657-2658 (2012
13. Schafer, S. A.,Machicao, F., Fritsche, A.,Haring, H. U.&Kantartzis, K. New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms. Diabetes Res. Clin. Pract. 93 Suppl 1, S9-24 (2011
14. Bain, J. R. et al. Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58, 2429-2443 (2009
15. Mai, M. et al. Serum levels of acylcarnitines are altered in prediabetic conditions. PLoS. ONE. 8, e82459 (2013
16. Then, C. et al. Plasma metabolomics reveal alterations of sphingo-and glycerophospholipid levels in non-diabetic carriers of the Transcription Factor 7-Like 2 polymorphism rs7903146. PLoS. ONE. 8, e78430 (2013
17. Spegel, P. et al.Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2). Diabetes 62, 653-661 (2013
18. Gloyn, A. L. et al. Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers. PLoS. ONE. 7, e40962 (2012
19. Nobrega, M. A. TCF7L2 and glucose metabolism: time to look beyond the pancreas. Diabetes 62, 706-708 (2013
20. da Silva Xavier,G. et al. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 58, 894-905 (2009
21. Savic, D. et al.Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism. Genome Res. 21, 1417-1425 (2011
22. Florez, J. C. et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355, 241-250 (2006 (Pubitemid 44079339)
23. Schafer, S. A. et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. Diabetologia 50, 2443-2450 (2007 (Pubitemid 350060632)
24. Nolan, C. J., Damm, P. & Prentki, M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378, 169-181 (2011
25. Linder, K. et al. Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals. PLoS. ONE. 7, e38224 (2012
26. Heni, M. et al. Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion. Diabetes 59, 3247-3252 (2010
27. Thamer, C. et al. Reduced skeletal muscle oxygen uptake and reduced beta-cell function: two early abnormalities in normal glucose-tolerant offspring of patients with type 2 diabetes. Diabetes Care 26, 2126-2132 (2003 (Pubitemid 41184263)
28. Wagner, R. et al. Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1. Mol. Metab 3, 261-267 (2014
29. Matsuda, M. & DeFronzo, R. A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470 (1999 (Pubitemid 29418240)
30. Huang, Q. et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 73, 4992-5002 (2013
31. Gika, H. G., Theodoridis, G. A., Wingate, J. E. & Wilson, I. D. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J. Proteome. Res. 6, 3291-3303 (2007 (Pubitemid 47310213)
32. Bijlsma, S. et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 78, 567-574 (2006). (Pubitemid 43100391)